<div id="readability-page-1"><ul><li>Last chance to set up your portfolio for OPEC cuts </li></ul><p>EnLink Midstream, Merck &amp; Co., Inc., Amgen, ProShares UltraPro Short QQQ, Mondelez International, Pfizer,  and PepsiCo are the seven Dividend stocks to watch today, according to MarketBeat's stock screener tool. Dividend stocks are shares of a company that pay out a portion of their earnings to shareholders on a regular basis. These payments, known as dividends, are usually distributed quarterly and provide investors with a steady stream of income in addition to any potential capital gains from the stock's appreciation. Companies that issue dividends typically have stable revenues and profits, making them an attractive option for income-oriented investors. These companies had the highest dollar trading volume of any Dividend stocks within the last several days.</p><div><p><span></span><span>Get <strong>EnLink Midstream</strong> alerts:</span></p></div><h2>EnLink Midstream (ENLC)</h2><p>EnLink Midstream, LLC provides midstream energy services in the United States. The company operates through Permian, Louisiana, Oklahoma, North Texas, and Corporate segments. It is involved in gathering, compressing, treating, processing, transporting, storing, and selling natural gas; fractionating, transporting, storing, and selling natural gas liquids; and gathering, transporting, stabilizing, storing, trans-loading, and selling crude oil and condensate, as well as providing brine disposal services.</p><p>Shares of ENLC stock traded up $0.41 during trading hours on Wednesday, reaching $14.56. The company's stock had a trading volume of 95,115,676 shares, compared to its average volume of 3,910,954. The firm's 50 day simple moving average is $14.69 and its 200-day simple moving average is $14.44. EnLink Midstream has a fifty-two week low of $11.55 and a fifty-two week high of $16.40. The company has a quick ratio of 0.42, a current ratio of 0.42 and a debt-to-equity ratio of 2.30. The company has a market capitalization of $6.65 billion, a price-to-earnings ratio of 69.33 and a beta of 2.43. </p><p>Read Our Latest Research Report on ENLC</p><h2>Merck &amp; Co., Inc. (MRK)</h2><p>Merck &amp; Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.</p><p>NYSE MRK traded down $0.88 on Wednesday, hitting $89.87. 14,747,370 shares of the company were exchanged, compared to its average volume of 12,946,326. The company has a market cap of $227.33 billion, a PE ratio of 18.86, a PEG ratio of 1.20 and a beta of 0.38. The company has a current ratio of 1.36, a quick ratio of 1.15 and a debt-to-equity ratio of 0.79. Merck &amp; Co., Inc. has a 12 month low of $87.33 and a 12 month high of $134.63. The stock has a fifty day moving average of $99.58 and a 200-day moving average of $107.12. </p><p>Read Our Latest Research Report on MRK</p><h2>Amgen (AMGN)</h2><p>Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout.</p><p>Shares of NASDAQ AMGN traded up $17.34 during trading on Wednesday, reaching $306.36. 3,917,162 shares of the stock traded hands, compared to its average volume of 3,163,888. The company has a debt-to-equity ratio of 7.55, a current ratio of 1.32 and a quick ratio of 0.96. The stock has a market capitalization of $164.68 billion, a P/E ratio of 39.17, a price-to-earnings-growth ratio of 2.87 and a beta of 0.56. Amgen has a 52-week low of $253.30 and a 52-week high of $346.85. The company has a 50-day moving average of $271.14 and a 200-day moving average of $303.52. </p><p>Read Our Latest Research Report on AMGN</p><h2>ProShares UltraPro Short QQQ (SQQQ)</h2><p>ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.</p><p>Shares of SQQQ stock traded down $0.29 on Wednesday, hitting $28.36. 30,629,357 shares of the company's stock traded hands, compared to its average volume of 54,988,281. The company's fifty day simple moving average is $29.95 and its 200 day simple moving average is $36.24. ProShares UltraPro Short QQQ has a one year low of $27.23 and a one year high of $64.95. </p><p>Read Our Latest Research Report on SQQQ</p><h2>Mondelez International (MDLZ)</h2><p>Mondelez International, Inc., through its subsidiaries, manufactures, markets, and sells snack food and beverage products in the Latin America, North America, Asia, the Middle East, Africa, and Europe. It provides biscuits and baked snacks, including cookies, crackers, salted snacks, snack bars, and cakes and pastries; chocolates; and gums and candies, as well as various cheese and grocery, and powdered beverage products.</p><p>Shares of NASDAQ:MDLZ traded up $0.71 during midday trading on Wednesday, reaching $56.83. The company's stock had a trading volume of 15,253,098 shares, compared to its average volume of 10,511,608. The firm has a 50 day moving average of $59.76 and a 200-day moving average of $66.53. The firm has a market capitalization of $75.99 billion, a P/E ratio of 20.15, a PEG ratio of 3.12 and a beta of 0.54. Mondelez International has a 12-month low of $53.95 and a 12-month high of $76.06. The company has a quick ratio of 0.42, a current ratio of 0.63 and a debt-to-equity ratio of 0.59. </p><p>Read Our Latest Research Report on MDLZ</p><h2>Pfizer (PFE)</h2><p>Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.</p><p>PFE traded up $0.67 during trading on Wednesday, hitting $26.54. 32,071,103 shares of the company's stock traded hands, compared to its average volume of 37,695,961. The company's 50 day simple moving average is $26.27 and its two-hundred day simple moving average is $27.79. Pfizer has a 12-month low of $24.48 and a 12-month high of $31.54. The stock has a market capitalization of $150.37 billion, a price-to-earnings ratio of 35.87, a PEG ratio of 0.66 and a beta of 0.64. The company has a current ratio of 1.00, a quick ratio of 0.73 and a debt-to-equity ratio of 0.63. </p><p>Read Our Latest Research Report on PFE</p><h2>PepsiCo (PEP)</h2><p>PepsiCo, Inc. engages in the manufacture, marketing, distribution, and sale of various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region.</p><p>PepsiCo stock traded up $1.71 during trading on Wednesday, reaching $145.20. The company had a trading volume of 5,720,643 shares, compared to its average volume of 6,819,082. The firm has a market capitalization of $199.21 billion, a price-to-earnings ratio of 21.41, a price-to-earnings-growth ratio of 2.92 and a beta of 0.54. The company has a current ratio of 0.89, a quick ratio of 0.70 and a debt-to-equity ratio of 1.96. The firm's 50-day simple moving average is $152.49 and its 200 day simple moving average is $164.53. PepsiCo has a 52 week low of $141.51 and a 52 week high of $183.41. </p><p>Read Our Latest Research Report on PEP</p><h2>Featured Articles</h2><ul><li>MarketBeat's Top Five Stocks to Own in February 2025</li><li>3 Must-Have ETFs Set to Dominate This Quarter</li><li>Seeking Stability? These 3 Stocks Offer Strong Potential</li><li>Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up</li><li>Alphabet Stock Dip: A Prime AI-Powered Buying Opportunity</li><li>Costco: A Retail Powerhouse Defying Economic Challenges</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in EnLink Midstream Right Now?</h2><p>Before you consider EnLink Midstream, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EnLink Midstream wasn't on the list.</p><p>While EnLink Midstream currently has a &#34;Hold&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ENLC

<p>On February 5th, MarketBeat highlights seven promising dividend stocks: EnLink Midstream, Merck & Co., Inc., Amgen, ProShares UltraPro Short QQQ, Mondelez International, Pfizer, and PepsiCo. These stocks are noted for their high trading volumes and regular dividend payments, appealing to income-oriented investors. EnLink Midstream's stock rose to $14.56, while Merck's shares fell to $89.87, and Amgen's stock increased to $306.36. These companies are recognized for their stable revenues and profits, making them attractive options for investors seeking steady income.</p>

Promising Dividend Stocks To Follow Today - February 05th